Established in 2020 Wednesday, October 27, 2021


Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents
Researchers analyzed blood samples collected in late 2020 and early 2021 from residents and staff of long-term care homes in the Metro Vancouver area. Image: Unsplash.



VANCOUVER.- A single dose of the Pfizer-BioNTech COVID-19 vaccine produces a much weaker antibody response in long-term care residents than it does in younger healthy adults, new research has found.

The pre-print findings, yet to be peer-reviewed, raise questions about the optimal timing of the second dose of vaccine for older adults.

“Results from this study in long-term care facilities in Vancouver reveal that individuals of advanced age, following the first dose of a two-dose vaccination regimen, are less able to generate as strong an antibody response, both in terms of magnitude and function, compared to adults of younger age,” says Dr. Marc Romney, clinical associate professor in University of British Columbia’s department of pathology and laboratory medicine, and medical leader for medical microbiology and virology at St. Paul’s Hospital, Providence Health Care. “It will be important to assess whether this observation extends to older persons living in the community as this may inform the optimal timing of the second dose for this population.”




Dr. Romney and the research team, co-led by Dr. Zabrina Brumme of the BC Centre for Excellence in HIV/AIDS and Dr. Mark Brockman of Simon Fraser University, analyzed blood samples collected in late 2020 and early 2021 from residents and staff of long-term care homes in the Metro Vancouver area.

Samples from 12 long-term care residents and 18 healthcare workers from the same network of long-term care facilities were taken before vaccination and provided a baseline against which the researchers could measure changes after participants received their first dose of vaccine.

Not only did the long-term care residents produce lower levels of antibodies than staff members after the first dose, the antibodies they did produce were less adept at blocking the SARS-CoV-2 virus from binding to its target cells.

“The antibody response was actively triggered in young, healthy people following a single dose of vaccine, while the response was clearly not as robust in older individuals. This indicates that some older people − not only in long-term care but also in the community − may be incompletely protected after their initial dose,” explains Dr. Romney.

“The study is one of the first to assess immune response to COVID-19 vaccines in this vulnerable population in Canada,” says Dr. Tim Evans, executive director of the COVID-19 Immunity Task Force, which funded the study. “The findings correspond with results from other countries that suggest the immune response to mRNA COVID-19 vaccines, as measured by these parameters, is less robust among older people, compared to younger persons. Fortunately, post-first dose infections leading to serious disease are exceedingly rare: real-world clinical evidence from Canada and the U.K. shows that older persons, in long-term care or in the community, are well-protected for many weeks by a single dose of an mRNA vaccine. Nevertheless, these findings are a reminder that there may be limits to how long we can stretch the time between doses for seniors and other segments of the population. Close post-vaccine surveillance, as is being done in many jurisdictions in Canada, is essential, and research correlating laboratory tests with clinical outcomes is needed.”







Today's News

March 28, 2021

Postcard from the edge... of a supermassive black hole

Does selfishness evolve? Ask a cannibal

Wisdom, loneliness and your intestinal multitude

Australian team gets to the heart of COVID-19

Control system helps several drones team up to deliver heavy packages

Iceland's volcanic eruption could be a long hauler

Fast-acting, color-changing molecular probe senses when a material is about to fail

Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents

Laser-driven experiments provide insights into the formation of the universe

Leveraging the 5G network to wirelessly power IoT devices

Africa's Covid 2nd wave was worse but saw fewer measures

Study finds evidence of Bartonella infection in schizophrenia patients

Therapeutic bed can help keep preterm newborns' brain oxygen levels stable

Repurposed heart and flu drugs may help body fight sepsis

Carrying naloxone can save lives but newly abstinent opioid users resist

Team studies new use for pulmonary hypertension drug



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful